“bloodwork without insurance 2026”的搜索结果，显示 51-60 项，共有 7132 项

1. 重症监护科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

2. 放射科- 临床试验- 妙佑医疗国际

   Rochester, Minn. VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

3. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

4. 血液科- 临床试验- 妙佑医疗国际

   In the initial study, some participants treated with linvoseltamab had improvement of their myeloma, including complete responses (no evidence of myeloma in ...

5. 外科 - 临床试验- 妙佑医疗国际

   ... no great support for either approach for patients with a smaller aorta. ... no great support for ... © 1998-2026 妙佑医疗国际医学教育与研究基金会（MFMER）。

6. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to better understand the anatomy of the lymphatic structure and the molecular process that leads to the over production of ...

7. 粪便潜血检查- 妙佑医疗国际

   了解医务人员如何使用粪便免疫化学检测等粪便潜血检查来筛查结肠癌。

8. 临床试验- 妙佑医疗国际儿童中心

   The information will be age, sex, race or ethnic group, immunologic lab ... without atopic dermatitis, and to apply mass ... © 1998-2026 妙佑医疗国际医学教育与研究 ...

9. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

10. 血液科- 临床试验- 妙佑医疗国际

    In the initial study, some participants treated with linvoseltamab had improvement of their myeloma, including complete responses (no evidence of myeloma in ...